The Effects of Stellate Ganglion Block Sleep in U.S. Active Duty Service Members and Veterans Receiving Prolonged Exposure Therapy for PTSD
The Effects of Stellate Ganglion Block on Sleep in U.S. Active Duty Service Members and Veterans Receiving Prolonged Exposure Therapy for Posttraumatic Stress Disorder (PTSD)
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Objectives: The primary objective of this project is to observe the impact of stellate ganglion block (SGB) on objective measures of sleep (using a wearable headband) and subjective measures of sleep (self-report measures) in active duty service members and veterans receiving prolonged exposure therapy (PE) for PTSD. The secondary objective is to evaluate sleep improvements as a mechanism for PTSD treatment outcomes in this population.
Specific Aim 1: To compare the effects of a SGB with ropivacaine (active) versus a SGB with saline (sham) on objective measures of sleep macroarchitecture (i.e., rapid eye movement [REM] sleep and slow wave sleep) and sleep continuity (i.e., sleep onset latency, wake after sleep onset, number of awakenings, total sleep time, and sleep efficiency).
Specific Aim 2: To compare the effects of SGB (active)+PE versus SGB (sham)+PE on sleep microarchitectural indicators of heightened central nervous system arousal (i. e., high-frequency and low-frequency power spectral density, frequency of occipital alpha-indexed micro-arousals, slow wave features [e.g., slope, density] during N3 sleep, proportion of phasic and tonic REM sleep and REM density during REM sleep).
Specific Aim 3: Specific Aim 3: To evaluate the effects of SGB (active)+PE versus SGB (sham)+PE on self-reported measures of insomnia and nightmares.
Studietyp
Inskrivning (Beräknad)
Kontakter och platser
Studiekontakt
- Namn: Kristi E Pruiksma, PhD, DBSM
- Telefonnummer: (210) 562-6700
- E-post: pruiksma@uthscsa.edu
Studieorter
-
-
Texas
-
Killeen, Texas, Förenta staterna, 76544
- Rekrytering
- Carl R. Darnall Army Medical Center at Fort Hood
-
Kontakt:
- Kristi E Pruiksma, PhD
- Telefonnummer: (210) 562-6700
- E-post: pruiksma@uthscsa.edu
-
Kontakt:
- Jennifer D Hein, MD
- Telefonnummer: 254-553-9779
- E-post: jennifer.m.hein6.mil@health.mil
-
San Antonio, Texas, Förenta staterna, 78229
- Rekrytering
- University of Texas Health Science Center at San Antonio
-
Kontakt:
- Kristi Pruiksma, PhD, DBSM
- Telefonnummer: 210-562-6700
- E-post: pruiksma@uthscsa.edu
-
Huvudutredare:
- Kristi Pruiksma, PhD, DBSM
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
- Vuxen
- Äldre vuxen
Tar emot friska volontärer
Testmetod
Studera befolkning
Beskrivning
Inclusion Criteria:
- Ability to provide informed consent and follow study-related instructions.
- Be randomized into the study titled "Combining Stellate Ganglion Block with Prolonged Exposure for PTSD: A Randomized Clinical Trial." NCT05889741
- Indicates willingness to wear the Sleep Profiler sleep monitor and to complete self-report assessments.
Exclusion Criteria:
1. Pre-existing skin or soft tissue condition that precludes the ability to wear the Sleep Profiler headband.
Studieplan
Hur är studien utformad?
Designdetaljer
Kohorter och interventioner
Grupp / Kohort |
Intervention / Behandling |
|---|---|
|
Massed Prolonged Exposure (PE) with SGB group
Participants will wear the EEG headband monitoring device (Sleep Profiler)for 3 nights as a baseline prior to SGB injection administered as part of enrollment in original study from which they were recruited.
After the SGB injection, participants will wear the headband monitoring device for 3 nights.
|
The headband is worn for 3 nights prior to injection and then for a an additional 3 nights after the injection.
Efficacy of the headband is not being tested, it is used as a measuring tool.
|
|
Massed PE Exposure with Sham SGB
Participants will wear the EEG headband monitoring device (Sleep Profiler) for 3 nights as a baseline prior to the sham SGB injection administered as part of enrollment in original study from which they were recruited.
Participants will wear the EEG headband monitoring device for 3 nights following the sham SGB injection.
|
The headband is worn for 3 nights prior to injection and then for a an additional 3 nights after the injection.
Efficacy of the headband is not being tested, it is used as a measuring tool.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Total Sleep Time
Tidsram: Sleep onset to awakening time (approximately 8 hours)
|
Time spent asleep from sleep onset to waking time
|
Sleep onset to awakening time (approximately 8 hours)
|
|
Wake time after sleep onset
Tidsram: Sleep onset to awakening time (approximately 8 hours)
|
Percentage of time spent awake after sleep onset
|
Sleep onset to awakening time (approximately 8 hours)
|
|
Rapid Eye Movement (REM) sleep state
Tidsram: Sleep onset to awakening time (approximately 8 hours)
|
Percentage of sleep time spent in REM
|
Sleep onset to awakening time (approximately 8 hours)
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Insomnia Severity Index
Tidsram: Baseline to 1 month
|
7-item self-report measure that assesses perceived severity of insomnia.
Each item uses a 4-point Likert type scale from 0 to 4. The items sum to produce a total score (range 0 - 28) with a higher score indicating
|
Baseline to 1 month
|
|
Nightmare Disorder Index (NDI)
Tidsram: Baseline to 1 month
|
The 5-item NDI evaluates for nightmare disorder in accordance with the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition criteria. Items are scored from 0-4 to give a total range between 0-20. Higher scores on the NDI indicate greater nightmare severity. |
Baseline to 1 month
|
|
Split Week Self-Assessment of Sleep Survey (SASS-Y) for Workdays
Tidsram: Baseline to 1 month
|
The Split Week SASS (SASS-Y) is a retrospective measure that assesses sleep parameters similar to a sleep diary including time to bed, number of awakenings, time of final awakening, and time out of bed, etc.
The Split Week version asks participants to estimate these parameters based on workdays.
|
Baseline to 1 month
|
|
Split Week Self-Assessment of Sleep Survey (SASS-Y) for off Days
Tidsram: Baseline to 1 month
|
The Split Week SASS (SASS-Y) is a retrospective measure that assesses sleep parameters similar to a sleep diary including time to bed, number of awakenings, time of final awakening, and time out of bed, etc.
The Split Week version asks participants to estimate these parameters based on days off of work.
|
Baseline to 1 month
|
Samarbetspartners och utredare
Samarbetspartners
Utredare
- Huvudutredare: Kristi E Pruiksma, PhD, DBSM, The University of Texas Health Science Center at San Antonio
Studieavstämningsdatum
Studera stora datum
Studiestart (Beräknad)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- STUDY00002535
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
IPD-planbeskrivning
Tidsram för IPD-delning
IPD-delning som stöder informationstyp
- STUDY_PROTOCOL
- SAV
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
produkt tillverkad i och exporterad från U.S.A.
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .